Dr. Yusun Zhou | Antimicrobial | Best Researcher Award

Posted on by Pencis

Dr. Yusun Zhou | Antimicrobial | Best Researcher Award

The Affiliated Hospital of Qingdao University | China.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Yusun Zhou completed his M.D. at Huazhong University of Science and Technology in 2015, providing him with a strong foundation in medicine. His academic journey was marked by a deep interest in clinical microbiology, which led him to pursue further research in microbial diagnostics.

💼PROFESSIONAL ENDEAVORS

After graduating, Zhou began his career at the Affiliated Hospital of Qingdao University, where he gained hands-on experience in clinical practice. Currently, he works at the Department of Clinical Microbiology Laboratory, applying his expertise to advance rapid microbial identification and resistance detection.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIMICROBIAL

Zhou is committed to the development and application of rapid detection techniques for microbial identification and antimicrobial resistance. His work has focused on innovating new diagnostic methods that are both efficient and cost-effective, crucial in the fight against the growing threat of antimicrobial resistance (AMR).

🌍IMPACT AND INFLUENCE

Zhou’s research has made a significant impact on clinical microbiology, contributing to the global effort to combat antimicrobial resistance. His studies have the potential to transform healthcare systems by enabling faster diagnoses and more targeted treatments, improving patient outcomes and enhancing public health globally.

📚ACADEMIC CITATIONS

His research has been recognized in numerous high-impact academic journals, including:

  • Journal of Nanobiotechnology
  • Microbial Cell Factories
  • MicrobiologyOpen
  • Journal of Clinical Laboratory Analysis
  • Chemical Engineering Journal
  • Talanta These publications underscore his contributions to the field of microbiology, particularly in diagnostic technologies and resistance mechanisms.

🏆RESEARCH GRANTS AND FUNDING

Zhou’s work has attracted funding and grants from various research bodies and academic institutions, allowing him to explore innovative technologies in microbial diagnostics and resistance. His research aligns with global priorities in infectious disease control and antimicrobial stewardship, making him a prominent figure in this domain.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Zhou is poised to leave a lasting legacy in the field of clinical microbiology. His research on rapid diagnostic techniques and antimicrobial resistance is paving the way for breakthroughs in both basic science and clinical applications. In the future, he will likely play a key role in shaping global health policy and healthcare practices related to infectious diseases and resistance management.

🌟A VISIONARY IN INFECTIOUS DISEASES

Zhou is a visionary in the realm of infectious diseases, particularly in the context of antimicrobial resistance. His innovative approach to rapid diagnostics reflects his commitment to tackling one of the most pressing challenges in modern medicine. By merging cutting-edge technology with clinical expertise, Zhou is laying the groundwork for future solutions to combat the growing crisis of drug-resistant infections.

📑NOTABLE PUBLICATIONS 

“A Magnetic Epitope-Imprinted Microsphere Used for Selective Separation and Rapid Detection of SHV-type β-lactamases in Bacteria: A Novel Strategy of Antimicrobial Resistance Detection”

Authors: Zhou, Y., Wang, K., Li, L., Wang, Q., Yu, B.
Year: 2024
Journal: Journal of Nanobiotechnology

“A Magnetic Molecularly Imprinted Electrochemical Sensor with Selective and Sensitive Detection Ability Towards Methotrexate in Serum Samples”

Authors: Sun, S., Li, S., Sun, Z., Tian, Q., Zhou, T.
Year: 2024
Journal: Journal of the Electrochemical Society

“Expression and Purification of Soluble Recombinant β-lactamases Using Escherichia coli as Expression Host and pET-28a as Cloning Vector”

Authors: Li, L., Li, H., Tian, Q., Zhu, Y., Zhou, Y.
Year: 2022
Journal: Microbial Cell Factories

“Magnetic Molecularly Imprinted Polymers for the Rapid and Selective Extraction and Detection of Methotrexate in Serum by HPLC-UV Analysis”

Authors: Zhou, T., Deng, Z., Wang, Q., Tian, Q., Lun, L.
Year: 2022
Journal: Molecules

“A Rapid and Highly Effective Approach for SARS-CoV-2 Nucleic Acid Daily Testing in More Than Four Thousand Single-Tube Samples”

Authors: Zhou, Y., Han, C., Li, H., Xuan, C., Tian, Q.
Year: 2022
Journal: Journal of Clinical Laboratory Analysis

Prof. Dr. Wei Zhang | Antibiotic | Best Researcher Award

Posted on by Pencis

Prof. Dr. Wei Zhang | Antibiotic | Best Researcher Award

Shandong University | China.

Author Profile

Orcid ID
🎓EARLY ACADEMIC PURSUITS

Wei Zhang, Ph.D., started his academic journey in bioengineering with a B.En. from Liaocheng University, China, in 2005. His passion for scientific inquiry led him to Xiamen University, where he pursued his M.S. (2005-2007) and Ph.D. (2007-2012) under the mentorship of Professors Yaojian Huang and Yuemao Shen. During this period, Dr. Zhang’s early research laid the foundation for his future work in bioengineering, focusing on molecular and cellular processes.

💼PROFESSIONAL ENDEAVORS

  • 2012: After completing his doctoral studies, Dr. Zhang began his academic career as an Assistant Professor at the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences.
  • 2014: He was promoted to Associate Professor at QIBEBT, where he expanded his research on bioengineering, particularly in antibiotics and bioenergy.
  • 2016-2017: Dr. Zhang took a postdoctoral position in Vanderbilt University, working under the guidance of Professor F. P. Guengerich, gaining expertise in the biochemical mechanisms involved in drug metabolism and infectious diseases.
  • 2018: He was recruited as a Full Professor at Shandong University, continuing his groundbreaking work in antibiotics and infectious disease research.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIBIOTICS

Dr. Zhang’s work has significantly contributed to the understanding and development of antibiotics and their mechanisms of action. His research delves into:

  • Antibiotic resistance mechanisms: Understanding how bacteria evolve resistance to current antibiotics.
  • Bioengineering solutions: Using biotechnology to design new antimicrobial agents that can bypass common resistance pathways.
  • Antibiotic biosynthesis: Studying natural microbial antibiotics for innovative treatments. His research is particularly relevant in the context of the global antibiotic resistance crisis, which has spurred him to focus on novel antimicrobial strategies.

🌍IMPACT AND INFLUENCE

Dr. Zhang’s academic influence spans both China and international scientific communities:

  • His collaborations with international labs (e.g., University of Nebraska-Lincoln and Vanderbilt University) have expanded his global network.
  • He has published extensively in high-impact journals, contributing significantly to the field of bioengineering and antibiotic research.
  • Dr. Zhang’s research on drug metabolism and bacterial resistance has the potential to reshape the future of infectious disease treatment, influencing policies, drug design, and healthcare practices worldwide.

📚ACADEMIC CITATIONS

Dr. Zhang has authored numerous scientific papers that have garnered widespread citation within the field of bioengineering and antibiotics. His work has been referenced by both academics and industry leaders, positioning him as a thought leader in bioengineering and antimicrobial research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Zhang has received substantial research funding from national and international sources, including:

  • China Scholarship Council: Supported his joint Ph.D. studies in the USA.
  • Multiple grants for antibiotic research, biotechnology innovations, and infectious disease solutions. These resources have enabled his lab to explore innovative research on antibiotic resistance, bioenergy, and microbial genomics.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhang’s contributions are paving the way for future innovations in combating antibiotic-resistant bacteria and exploring novel bioengineering solutions:

  • His work in biosynthesis and bioengineering will likely lead to next-generation antibiotics.
  • Future research initiatives are focused on integrating artificial intelligence with antibiotic development, ensuring that new, sustainable treatments emerge in a rapidly changing microbiome.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Zhang’s visionary approach lies in leveraging biotechnology, bioengineering, and molecular biology to develop the next frontier of antimicrobials. As a scientific leader, he emphasizes:

  • Collaborative research to bridge the gap between academia and industry.
  • Sustainable solutions for global health challenges, particularly in the area of antibiotic resistance.

📑NOTABLE PUBLICATIONS 

“Engineering Bafilomycin High-Producers by Manipulating Regulatory and Biosynthetic Genes in the Marine Bacterium Streptomyces lohii”

Authors: Wei Zhang
Publication Year: 2021
Journal: Marine Drugs

“Structural Basis for Selective Oxidation of Phosphorylated Ethylphenols by Cytochrome P450 Monooxygenase CreJ”

Authors: Wei Zhang
Publication Year: 2021
Journal: Applied and Environmental Microbiolog

“Structural Basis for Substrate Specificity of the Peroxisomal Acyl-CoA Hydrolase MpaH’ Involved in Mycophenolic Acid Biosynthesis”

Authors: Wei Zhang
Publication Year: 2021
Journal: FEBS Journa

“Engineering Cytochrome P450 Enzyme Systems for Biomedical and Biotechnological Application”

Authors: Wei Zhang
Publication Year: 2020
Journal: Journal of Biological Chemistr

“Fungal-Derived Brevianamide Assembly by a Stereoselective Semipinacolase”

Authors: Wei Zhang
Publication Year: 2020
Journal: Nature Catalysis

Prof. Fangfang Chen | Nanomedicine | Best Researcher Award

Posted on by Pencis

Prof. Fangfang Chen | Nanomedicine | Best Researcher Award

Jilin university | China.

Author Profile

Scopus
Orcid ID
🎓EARLY ACADEMIC PURSUITS

Dr. Fang-Fang Chen embarked on her academic journey with a Ph.D. in Immunology from the Norman Bethune College of Medicine of Jilin University in 2010, where her thesis focused on Leukemia Cell Apoptosis-Related Genes. She also earned a Master’s degree in Immunology in 2007, studying Human Follistatin and MUC1 histological expressions. In 2002, she completed her M.D. in Clinical Medicine from the same prestigious institution.

💼PROFESSIONAL ENDEAVORS

Dr. Chen has held various influential academic positions:

  • Professor at the Nanomedical Translational Research Center, China-Japan Union Hospital of Jilin University since 2018, where she focuses on nanomedicine.
  • She also serves as a Professor in the Laboratory of Gastrointestinal Colorectal and Anal Surgery since 2017.
  • Previously, she was a Postdoctoral Fellow in the Department of Nanomedicine, Colorado University (2014-2016).
  • Her clinical career includes roles as a Physician in Neurology at the Sixth Hospital of Guangzhou (2002-2005).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE

Dr. Chen is recognized for her work in nanomedicine, particularly focusing on nanoworm-based targeted therapies for leukemia and cancer immunotherapy. Her research on superparamagnetic iron oxide nanoworms (SPIO) conjugated with monoclonal antibodies has shown promise in targeted therapies for acute myeloid leukemia and B-lymphoblastic leukemia. Her groundbreaking work in DNA sequencing techniques also extends to the exploration of immune mechanisms in cancer and leukemia therapies.

🌍IMPACT AND INFLUENCE

Dr. Chen’s work has a significant impact on both nanomedicine and cancer immunotherapy, particularly in leukemia treatment. She has shaped the landscape of targeted cancer therapies through her innovative research on nanotechnology in the field of oncology. Her contributions to immunology and nanomedicine have earned her recognition and awards, including the 17th China Young Women Scientist Award in 2022 and multiple accolades for her leadership in scientific advancements.

📚ACADEMIC CITATIONS

Dr. Chen’s research has been widely cited, particularly for her contributions to nanomedicine and cancer immunotherapy. Her projects, including the superparamagnetic iron oxide nanoworm studies, are frequently referenced in scientific literature, demonstrating her influence in the field of cancer biology and targeted therapies. Her work continues to provide new insights into the immune mechanisms involved in leukemia.

🏆RESEARCH GRANTS AND FUNDING

Dr. Chen has secured multiple prestigious research grants, reflecting her leadership in advancing nanomedicine and cancer therapy:

  • National Natural Science Foundation of China: For projects on Feumoxytol in leukemia therapy (2023-2026) and superparamagnetic iron oxide nanoworms in leukemia treatment (2018-2020).
  • Jilin University: Seed funding for distinguished young scholars in nanomedicine (2017) and several other major grants in cancer research.
  • Her research projects are supported by various national and provincial foundations, allowing her to explore targeted immunotherapy, leukemia, and cancer biomarkers.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Chen’s career is not just about research but also about education and mentorship. As a professor, she is shaping the next generation of scientists in nanomedicine and cancer therapy. Her legacy is cemented in her ongoing contributions to medical research, particularly in the development of novel cancer therapies and personalized medicine. Her future contributions are poised to further transform the medical landscape, especially in oncology and immunology.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Fang-Fang Chen is a visionary in the field of infectious diseases and cancer immunotherapy, focusing on nanotechnology-based treatments. Her work in immune mechanisms and DNA sequencing is helping pave the way for more effective targeted therapies and personalized treatments for a range of diseases, including leukemia.

📑NOTABLE PUBLICATIONS 

“Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity”

Authors: Li, Y., Wu, W., Liu, Q., Gao, M., Chen, F.
Publication Year: 2024
Journal: Nature Communications
Citations: 0

“Atomic Interface Engineering-Mediated Metallene Nanozyme Boosts Efficient Photothermal Catalytic Tumor-Specific Therapy”

Authors: Wu, J., Jiao, D., Liu, Q., Cui, X., Chen, F.
Publication Year: 2024
Journal: Advanced Functional Materials
Citations: 2

“Emerging Roles of Graphitic Carbon Nitride-based Materials in Biomedical Applications”

Authors: Zhang, Y., Sun, S., Wu, Y., Chen, F.
Publication Year: 2024
Journal: ACS Biomaterials Science and Engineering
Citations: 1

“Tensile Strain-Mediated Bimetallene Nanozyme for Enhanced Photothermal Tumor Catalytic Therapy”

Authors: Wu, J., Liu, Q., Jiao, D., Cui, X., Chen, F.
Publication Year: 2024
Journal: Angewandte Chemie – International Edition
Citations: 8

“A biomimetic ion channel shortens the QT interval of type 2 long QT syndrome through efficient transmembrane transport of potassium ions”

Authors: Sun, S., Xu, Z., Lin, Z., Chen, F., Dong, Z.
Publication Year: 2024
Journal: Acta Biomaterialia
Citations: 2

 

Dr. Ying Zhang | Respiratory Infectious Diseases | Best Researcher Award

Posted on by Pencis

Dr. Ying Zhang | Respiratory Infectious Diseases | Best Researcher Award

 The First Hospital of Jilin University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Zhang Ying began her academic journey in 2002 when she enrolled in the seven-year clinical medicine program at Jilin University. Upon graduating in 2009, she gained a solid foundation in clinical practice and medical sciences. Driven by a passion for research excellence, she continued her academic pursuits and obtained her Doctor of Science degree in 2020, marking the culmination of her academic dedication and commitment to advancing the field of pediatric respiratory medicine. This achievement reflects her expertise in both clinical medicine and scientific research.

🩺PROFESSIONAL ENDEAVORS

  • Current Position: Consultant Physician in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University.
  • Clinical Expertise: Zhang specializes in pediatric respiratory diseases, offering both clinical care and research leadership. She is focused on diagnosing and treating complex respiratory infections and diseases in children, leveraging her extensive knowledge and expertise to improve patient outcomes.
  • Research Leadership: In addition to her clinical work, Zhang has pioneered research that bridges the gap between clinical care and molecular medicine, particularly in respiratory infectious diseases.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON RESPIRATORY INFECTIOUS DISEASES

Zhang Ying’s research is dedicated to advancing the understanding and treatment of respiratory infectious diseases, with a strong emphasis on precision medicine and molecular diagnostics:

  1. Extracellular Vesicles in Respiratory Diseases: Zhang’s research explores the role of extracellular vesicles in diseases like chronic obstructive pulmonary disease (COPD), offering insights into potential biomarkers and therapeutic targets.
  2. Pathogen Identification and Drug Resistance: She has developed innovative methods for rapid identification and drug resistance screening of respiratory pathogens using single-cell Raman spectroscopy, a cutting-edge approach in molecular diagnostics.

🌍 IMPACT AND INFLUENCE

Zhang Ying has made a profound impact in the field of infectious diseases, particularly in pediatric respiratory care. Through her research, she has enhanced the understanding of the molecular mechanisms behind respiratory infections, providing valuable insights into precision medicine and personalized therapies. Her work has influenced both clinical practice and molecular diagnostics, offering innovative solutions to improve outcomes for children with complex respiratory conditions.

📚 ACADEMIC CITATIONS

  • A new frontier in precision medicine: Exploring the role of extracellular vesicles in COPD – Biomedicine & Pharmacotherapy, 2024.
  • Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy – Front. Microbiol., 2023.
  • Aerosolization inhalation of non-typeable Haemophilus influenzae outer membrane vesicles contributing to neutrophilic asthma – Front. Microbiol., 2023.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Zhang Ying’s research has paved the way for major advancements in respiratory infectious diseases, particularly for pediatric patients. Her work on extracellular vesicles, exosomes, and molecular diagnostics has the potential to revolutionize how respiratory infections are diagnosed and treated. Her legacy will continue through her contributions to personalized medicine, improving the early detection and targeted treatment of respiratory diseases in children.

📑 NOTABLE PUBLICATIONS 

“A new frontier in precision medicine: Exploring the role of extracellular vesicles in chronic obstructive pulmonary disease”

Authors: Gou, Z., Yang, H., Wang, R., Liu, Z., Zhang, Y.

Journal: Biomedicine and Pharmacotherapy

Year: 2024

Citations: 2

“Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy”

Authors: Liu, Z., Xue, Y., Yang, C., Li, B., Zhang, Y.

Journal: Frontiers in Microbiology

Year: 2023

Citations: 6

“Aerosolization inhalation of non-typeable Haemophilus influenzae outer membrane vesicles contributing to neutrophilic asthma”

Authors: Zhang, Y., Wang, H., Zhang, Y., Zhao, P., Li, Y.

Journal: Frontiers in Microbiology

Year: 2023

Citations: 5

“Exosomes in HBV infection”

Authors: Liu, Z., Li, Y., Wang, Y., Bai, X., Zhang, Y.

Journal: Clinica Chimica Acta

Year: 2023

Citations: 17

“Engineering Coinage Metal Nanoclusters for Electroluminescent Light-Emitting Diodes”

Authors: Li, T., Wang, Z., Zhang, Y., Wu, Z.

Journal: Nanomaterials

Year: 2022

Citations: 4

Prof. Zhiyi He | Immunology of Infections | Best Researcher Award

Posted on by Pencis

Prof. Zhiyi He | Immunology of Infections | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Professor Zhiyi He embarked on his academic journey with a focus on respiratory medicine, excelling during his medical training. His dedication to advancing healthcare led him to pursue rigorous education and research, establishing a strong foundation for his future endeavors.

🩺PROFESSIONAL ENDEAVORS

Position: Professor and Doctoral Supervisor at The First Affiliated Hospital of Guangxi Medical University.

Roles:

  • Member of the Respiratory Society of the Chinese Medical Association.
  • Young Member of the Chinese Respiratory Society.
  • Member of the COPD Group of the Chinese Respiratory Society.
  • Chairman of the Respiratory Disease Branch of the Guangxi Medical Association.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOLOGY OF INFECTIONS

Professor Zhiyi He’s research is pivotal in addressing chronic respiratory diseases, with a particular emphasis on:

  • Chronic Obstructive Pulmonary Disease (COPD).
  • Advancing diagnostic and therapeutic approaches for respiratory illnesses.
  • Promoting interdisciplinary research to integrate cutting-edge treatments.

🌍IMPACT AND INFLUENCE

Professor He’s contributions have significantly shaped respiratory medicine, not only within Guangxi but across China. As the Chairman of the Respiratory Disease Branch of the Guangxi Medical Association, he has spearheaded initiatives to improve healthcare accessibility and quality for patients with chronic respiratory conditions.

📚ACADEMIC CITATIONS

With numerous publications in high-impact journals, Professor Zhiyi He is widely cited in the fields of respiratory medicine and clinical research. His work has influenced academic peers and practitioners, reflecting his stature as a thought leader in his domain.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Achievements: Named the 2020 Outstanding Scholar of Guangxi Colleges and Universities, a testament to his enduring contributions to academia and healthcare.

Vision: Professor He aims to continue driving innovation in respiratory medicine through mentorship, research, and clinical practice, leaving a lasting legacy for future generations of medical professionals.

📑NOTABLE PUBLICATIONS 

“Multiple pathogen infections accompanied with ocular pathologies in a patient with high-titer Anti-IFN-γ autoantibodies: a case report” 

Authors: Wu, S., Liang, S., Liang, H., Li, X., He, Z.
Journal: BMC Infectious Diseases
Publication Year: 2024

“Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial” 

Authors: Zhou, Y., Wu, F., Shi, Z., Liu, S., Zhao, Z.
Journal: Nature Communications
Year: 2024

“Polyphyllin B inhibited STAT3/NCOA4 pathway and restored gut microbiota to ameliorate lung tissue injury in cigarette smoke-induced mice” 

Authors: Wang, Q., He, Z., Zhu, J., Yang, L., Yang, H.
Journal: BMC Biotechnology
Year: 2024

“Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-γ autoantibodies: a case report” 

Authors: Ning, Y., Yu, Q., Liang, H., Liang, X., He, Z.
Journal: BMC Infectious Diseases
Year: 2024

“Mechanism of cigarette smoke in promoting small airway remodeling in mice via STAT 3 / PINK 1-Parkin / EMT” 

Authors: Wei, Y., Li, Q., He, K., Li, M., He, Z.
Journal: Free Radical Biology and Medicine
Year: 2024

Prof. Shu-Ching Hsu | Immunology of Infections | Best Researcher Award

Posted on by Pencis

Prof. Shu-Ching Hsu | Immunology of Infections | Best Researcher Award

Prof. Shu-Ching Hsu, National Health Research Institute/National Institute of Infectious Diseases and Vaccinology, Taiwan.

Prof. Shu-Ching Hsu is an Associate Investigator at the National Institute of Infectious Diseases and Vaccinology (NIIDV), NHRI, Taiwan. She earned her Ph.D. in Molecular Immunology and Signal Transduction from National Taiwan University and specializes in immunology, stem cell biology, and vaccine development. Prof. Hsu is widely recognized for her pioneering research on immune suppression, neutrophil biology, and the development of humanized mouse models to study immune responses in infectious diseases. Her work has significantly advanced immunotherapy, drug discovery, and our understanding of immune mechanisms in disease progression. She was honored with the Best Researcher Award for her exceptional contributions to the field of immunology and infectious diseases.

Author Profile

Scopus

🏫EARLY ACADEMIC PURSUITS

Dr. Shu-Ching Hsu earned her Ph.D. in Molecular Immunology and Signal Transduction from the Graduate Institute of Microbiology, National Taiwan University (1995–2000). Prior to this, she completed her M.S. in Molecular Biology and Immunology at National Yang-Ming University (1993–1995) and her B.S. in Microbiology from Soochow University (1989–1993).

💼 PROFESSIONAL ENDEAVORS

Dr. Shu-Ching Hsu has extensive professional experience in both research and academia. She is currently an Associate Investigator at the National Institute of Infectious Diseases and Vaccinology (NIIDV), NHRI, Taiwan (2013–present) and holds Associate Professor positions at National Chung Hsing University, National Defense University, and Kaohsiung Medical University (2013–present). Prior to her current roles, she served as an Assistant Investigator at the Vaccine Research and Development Center, NHRI, Taiwan (2005–2013). Dr. Hsu also completed two postdoctoral fellowships: one at Tulane University, USA (2002–2005) and another at Academia Sinica, Taiwan (2000–2002).

🔬RESEARCH INTERESTS

Dr. Shu-Ching Hsu’s research interests focus on human neutrophil biology and progenitor cell differentiation, as well as the development of humanized mouse models for advancing immunotherapy and drug discovery. She is also deeply engaged in understanding the mechanisms of immune suppression, particularly through myeloid-derived suppressive cells (MDSCs), and their role in disease progression. Additionally, Dr. Hsu explores stem cell-based therapies aimed at addressing infectious diseases, cancer, and various immune disorders.

🧠TECHNICAL SKILLS

Dr. Shu-Ching Hsu possesses expertise in stem cell biology, particularly in the development and use of humanized mouse models for immunotherapy and drug discovery. She is proficient in neutrophil biology, cell signaling, and understanding immune suppression mechanisms. Additionally, Dr. Hsu is skilled in the genetic modification of hematopoietic stem cells (HSCs) and the creation of stem cell-derived immune cell platforms for research and therapeutic applications.

📑 NOTABLE PUBLICATIONS 

“IL-10RA governs the expression of IDO in the instruction of lymphocyte immunity” 

Authors: Tai, T.-S., Hsu, D.-W., Yang, Y.-S., Wu, C.-H., Hsu, S.-C.
Publication Year: 2024
Citations: 0

“Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein” 

Authors: Chiu, Y.-S., Wu, K.-J., Yu, S.-J., Wang, Y., Chen, Y.-H.
Publication Year: 2023
Citations: 1

“Correction: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells” 

Authors: Chan, T.-S., Hsu, C.-C., Pai, V.C., Weaver, V.M., Tsai, K.K.
Publication Year: 2023
Citations: 0

“The potential of adoptive transfer of γ9δ2 T cells to enhance blinatumomab’s antitumor activity against B-cell malignancy” 

Authors: Chen, Y.-H., Wang, Y., Liao, C.-H., Hsu, S.-C.
Publication Year: 2021
Citations: 4

“Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction” 

Authors: Ko, Y.-C., Lai, T.-Y., Hsu, S.-C., Lin, C.-Y., Lin, S.-F.
Publication Year: 2020
Citations: 19

“Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody” 

Authors: Chen, Y.-H., Yu, S.-J., Wu, K.-J., Hoffer, B.J., Wang, Y.
Publication Year: 2020
Citations: 7

Prof. Saber Imani | Mpox | Best Researcher Award

Posted on by Pencis

Prof. Saber Imani | Mpox | Best Researcher Award

Prof. Saber Imani, Zhejiang Shuren University, China.

Prof. Saber Imani is an accomplished researcher and educator in oncology, with expertise in cancer immunology, epigenetics, and therapeutic technologies. He holds an Assistant Professorship at Zhejiang Shuren University, China, and has a distinguished career spanning institutions in Iran, China, and the USA. Prof. Imani’s research focuses on innovative cancer therapies, including mRNA vaccines and nano-cancer treatments, and he has published over 110 scientific papers with significant citations. His mentorship and active involvement in global oncology organizations underscore his leadership in advancing cancer research.

Professional Profile

Scopus Profile

📚Education

Prof. Saber Imani holds a Ph.D. in Molecular Medicine from Baqiyatallah University of Medical Sciences, Tehran, Iran (2011-2015), awarded on 20/11/2015. He completed his Master of Science in Cellular and Molecular Biology at the Department of Biology, College of Science, IHU, Tehran, Iran (2009-2011), with the degree awarded on 01/09/2011. Prior to that, he earned his Bachelor of Science in Microbiology from the Department of Biology, College of Science, IHU, Tehran, Iran (2005-2009), graduating on 21/07/2009. He also attended Junior High School and High School with a major in Sciences (2001-2005).

💼Experience

Prof. Saber Imani has extensive professional experience in the field of oncology and genomics. He served as an Assistant Professor of Translational Oncology at the Department of Oncology, The Affiliated Hospital of Southwest Medical University in Sichuan, P.R. China, from 2020 to 2022. Prior to that, he was a Postdoctoral Fellow of Translational Genomics at the Pediatrics Department, Washington University School of Medicine, St. Louis, MO, USA, from 2019 to 2020. Additionally, he worked as a Postdoctoral Fellow of Cancer Epigenetics at the Key Laboratory of Epigenetics, Zhejiang University, Hangzhou, P.R. China, from 2015 to 2018, with his award date being 10/05/2018.

 

🔬Research Interest

Prof. Saber Imani’s research interests focus on several cutting-edge areas in cancer treatment and genomics. His work includes the development of mRNA cancer vaccines, translational immune-oncology, and genomics oncology. He is also deeply engaged in cancer epigenetics and exploring innovative approaches like nano cancer therapy to improve cancer treatment outcomes. These areas of research reflect his commitment to advancing the understanding and treatment of cancer through novel, targeted therapeutic strategies.

 

🧠Skills

Prof. Saber Imani possesses a diverse and comprehensive skill set across languages, laboratory techniques, bioinformatics, and computer software. He is proficient in English, Turkish (native), Persian, and is currently learning Chinese. In the laboratory, he is skilled in extractions (DNA, protein, polymers, cell extracts), various types of PCR (including Reverse Transcriptase, Real-Time, and LAMP), and immunology techniques such as blood typing and antigen-antibody interactions. He has extensive experience in cell screening (mesenchymal cells, bacterial cells, enzymes), cell culture (mesenchymal, plant, bacterial cells), and cloning (bacterial and animal cells). Prof. Imani is also proficient in flow cytometry, primer design (using tools like Oligo 6 and Generunner), and sequence alignment with platforms such as CLC workbench, BLAST, and GeneDock. His expertise extends to bioinformatics (including homology-based modeling, dynamics modeling, and alignment) and next-generation sequencing using Illumina MiSeq services. On the computer front, he is highly skilled in Microsoft Office, Adobe Photoshop, and scientific tools such as SPSS, Flowjo, AutoDock, MiSeq Control Software (MCS), and GROMCS V 4.5.5.

🎖️Honors and Achievements

Prof. Saber Imani has achieved numerous prestigious honors throughout his academic and professional career. In 2019, he was appointed Ambassador of the European Association for Cancer Research (EACR) in Sichuan Province, China. He also received the Sichuan Province Medical Science and Technology Award in 2018. As a leading expert in his field, Prof. Imani is an active member of top organizations such as the European Society for Medical Oncology (ESMO) and the American Association for Cancer Research (AACR). His academic excellence is demonstrated by his receipt of the Ph.D. Scholarship from the CAS-TWAS President’s Fellowship Program in 2015. Prof. Imani’s academic journey also includes being named The Nation’s Top Student in Biology in Iran (2011-2012) and securing the 1st rank among 20 graduates in his Master’s program, as well as the 2nd rank among 45 graduates in his Bachelor’s program. He also earned 3rd place in the International Technology, Invention of West Asia (ITI) competition (2010-2011). His scholarly impact is reflected in his Saber Statistics, which include 112 ISC papers, an impressive mean impact factor of 8.23, 2,141 citations, and an h-index of 27.

🎙️Teaching sessions

Prof. Saber Imani’s teaching activities include a range of courses aimed at providing students and scientists with crucial knowledge and practical skills. The “Targeted Cancer Therapy” course explores the key concepts of precision oncology, guiding students through topics such as genomic analysis, cancer biomarkers, risk assessment of chronic diseases, and gene-environment interactions, while bridging the gap from bench to bedside and population health. The “Cancer Epigenetics Course” complements this by offering in-depth exploration of epigenetic mechanisms in cancer, with additional resources from Prof. Imani’s e-book, “Epigenetics in Cancer” (Alpha Science Inter. Pub., Oxford, UK & Science Press, Beijing, China). Finally, the “Scientific Writing Course” helps students and scientists improve their writing skills by covering essential topics like scientific manuscript preparation, grant writing, pre-review, and ethical issues in scientific publication, with practical exercises aimed at reducing writing anxiety and enhancing clarity for both scientific and general audiences.

📑Top Note Publications

Title: Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions

Authors: Imani, S., Aminnezhad, S., Alikarami, M., Maghsoudloo, M., Taheri, Z.
Publication Year: 2024
Citations: 0

Title: Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact

Authors: Imani, S., Tagit, O., Pichon, C.
Publication Year: 2024
Citations: 5

Title: Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinom

Authors: Roozitalab, G., Abedi, B., Imani, S., Farghadani, R., Jabbarzadeh Kaboli, P.
Publication Year: 2024
Citations: 3

Title: Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development

Authors: Yu, H., Xu, Y., Imani, S., Ullah, S., Wang, Q.
Publication Year: 2024
Citations: 1

Title: The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies

Authors: Imani, S., Roozitalab, G., Emadi, M., Behzadi, P., Jabbarzadeh Kaboli, P.
Publication Year: 2024
Citations: 0

Assoc. Prof. Dr. Weiqing Zhuang | Vector-Borne Diseases | Best Researcher Award

Posted on by Pencis

Assoc. Prof. Dr. Weiqing Zhuang | Vector-Borne Diseases | Best Researcher Award

Assoc. Prof. Dr. Weiqing Zhuang , Fujian University of Technology, China.

Dr. Weiqing Zhuang, born in October 1981, is a prominent scholar in the fields of management and big data analytics. He is currently the President of the School of Internet Economics and Business at Fujian University of Technology, as well as a professional leader at JD Zhilian Cloud Industry College. His academic career has been marked by significant contributions to digital business applications and research in big data.

Professional Profiles

Scopus Profile

Orcid Profile

🎓Education

Dr. Zhuang holds a Ph.D. in Management from Xiamen University and completed his postdoctoral fellowship in Big Data Statistics at the University of Central Florida, USA. His strong academic foundation has supported his distinguished career in higher education and research.

 

💼Experience

As the President of the School of Internet Economics and Business at Fujian University of Technology, Dr. Zhuang leads a vibrant academic team. He is also an Associate Professor at the same university and serves as the Professional Leader of JD Zhilian Cloud Industry College. His leadership roles have allowed him to foster innovation in internet economics and big data education.

 

🔍Research Interest

Dr. Zhuang’s research primarily focuses on big data analytics and its applications in digital business, aiming to explore how data-driven decision-making can enhance business strategies and outcomes across various sectors.

 

👩‍🏫Technical Skills

With expertise in data analytics and big data statistical methods, Dr. Zhuang is skilled at applying cutting-edge technologies to solve real-world business challenges, particularly in the digital space.

 

📚Academic Achievements

Over his career, Dr. Zhuang has hosted more than 30 research projects and published nearly 70 academic papers, including in high-impact journals such as the Journal of Business Research. He has also served on the editorial board of international journals and as a reviewer for numerous prestigious academic publications.

👨‍🏫Teaching Experience

As an educator, Dr. Zhuang leads courses in internet economics, business, and data analytics. His teaching style emphasizes practical, data-driven approaches to solving modern business problems, preparing students for success in a rapidly evolving digital economy.

📑Top Note Publications

Title: Data Analysis and Prediction for Emergency Supplies Demand Through Improved Dynamics Model: A Reflection on the Post Epidemic Era

Authors: Zhuang, W., Wu, Q., Wang, M.C.
Publication Year: 2024
Citations: 0

Title: An Evolutionary Game-Based Regulatory Path for Algorithmic Price Discrimination in E-Commerce Platforms

Authors: Guo, Y., Lin, J., Zhuang, W.
Publication Year: 2024
Citations: 0

Title: PDSMNet: Parallel pyramid dual-stream modeling for automatic lung COVID-19 infection segmentations

Authors: Nakamoto, I., Zhuang, W., Chen, H., Guo, Y.
Publication Year: 2024
Citations: 1

Title: Short-Term Traffic Flow Prediction Based on a K-Nearest Neighbor and Bidirectional Long Short-Term Memory Model

Authors: Zhuang, W., Cao, Y.
Publication Year: 2023
Citations: 17

Title: The implications of internet-based Chinese language courses on online classes

Authors: Khan, R., Zhuang, W.
Publication Year: 2023
Citations: 0

Title: The impact of agricultural intensification on carbon dioxide emissions and energy consumption: A comparative study of developing and developed nations

Authors: Khan, R., Zhuang, W., Najumddin, O., Ahmad, I., Al-Faryan, M.A.S.
Publication Year: 2022
Citations: 8

Ms. Ziyi Wang | Immunology of Infections | Best Researcher Award

Posted on by Pencis

Ms. Ziyi Wang | Immunology of Infections | Best Researcher Award

Ms. Ziyi Wang, Wenzhou Medical University, China.

Ms. Ziyi Wang is a researcher specializing in the immunology of infections, with a focus on understanding how the immune system responds to various pathogens. Currently pursuing a Master’s degree in Epidemiology and Medical Statistics at Wenzhou Medical University, she has made significant contributions to the study of infection-related biomarkers and immune responses. Ziyi’s research has earned her the Best Researcher Award, recognizing her innovative work in identifying immune mechanisms and biomarkers that could inform better diagnostics and treatments for infectious diseases. Her dedication to advancing the field has led to her publication of multiple research articles in peer-reviewed journals.

Professional Profiles

Scopus Profile

📚Education

Ms. Ziyi Wang is currently pursuing a Master’s degree in Epidemiology and Medical Statistics at Wenzhou Medical University in Wenzhou, Zhejiang, China. Her academic focus includes researching biomarkers related to diabetes and its complications, particularly in the context of diabetic retinopathy. She has gained a strong foundation in statistical analysis, epidemiological research methods, and disease modeling, with an emphasis on applying these skills to medical and public health issues. Her studies also integrate practical research experience, contributing to her ongoing work in diabetes-related research.

💼Experience

Ms. Ziyi Wang is currently conducting research on biomarkers for diabetic retinopathy (DR), with a specific focus on the role of plasma OA levels. Her work aims to investigate how OA levels could serve as a potential biomarker for early detection and effective management of DR, a common and vision-threatening complication of diabetes. By employing various statistical methods and analytical approaches, her research seeks to better understand the relationship between OA levels and DR risk, contributing to improved diagnostic models and potential clinical interventions for patients with diabetes.

🔬Research Interest

Ms. Ziyi Wang’s research interests focus on biomarkers for diabetic retinopathy (DR), with a particular emphasis on their potential for early detection and effective management of the condition. She is dedicated to exploring the underlying mechanisms of diabetes complications and how specific biomarkers can be utilized for improved diagnosis and treatment. Additionally, her research seeks to identify and explore new treatment targets for DR, aiming to contribute to the development of more targeted and effective therapeutic strategies for managing this vision-threatening complication of diabetes.

👩‍🏫Technical Skills

Ms. Ziyi Wang is proficient in a wide range of technical skills, including statistical analysis, epidemiological modeling, and biomarker detection. She applies advanced statistical methods to analyze complex data and model disease patterns, particularly in the context of diabetes and its complications. Her expertise in biomarker detection allows her to identify key indicators that contribute to the early detection and management of conditions like diabetic retinopathy. Additionally, Ziyi is well-versed in various research methodologies, ensuring the rigorous design, execution, and analysis of her studies to produce reliable and impactful scientific results.

🎤Academic Citations

Ms. Ziyi Wang has published three articles in academic journals, making significant contributions to the field of diabetes research, particularly in the area of biomarkers for diabetic complications. Her research focuses on identifying key biomarkers that can aid in the early detection and management of diabetes-related complications, such as diabetic retinopathy. These publications have helped expand the understanding of the role of biomarkers in diabetes and have provided valuable insights into potential diagnostic tools and treatment strategies, further advancing the knowledge in this critical area of medical research.

📑Top Note Publications

Title: The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou

Authors: Wang, Y., Yang, Z., Li, J., Jin, M., Mao, G.
Publication Year: 2024
Citations: 0

Title: Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co-expression network analysis and machine learning techniques

Authors: Che, M., Xia, Z., Jiang, D., Zheng, C., Mao, G.
Publication Year: 2023
Citations: 0

Title: Title: Anemia is independently associated with mortality in people living with human immunodeficiency virus/acquired immune deficiency syndrome: A propensity score matching-based retrospective cohort study in China

Authors: Jin, M., Wang, Y., Li, J., Yang, Z., Mao, G.
Publication Year: 2023
Citations: 3

 

Huaibing Jin | Vector-Borne Diseases | Best Researcher Award

Posted on by Pencis

Huaibing Jin | Vector-Borne Diseases | Best Researcher Award

Prof. Huaibing Jin , Chinese Academy of Agricultural Sciences Institute of Plant Protection, China.

Huaibing Jin is a distinguished researcher in vector-borne diseases, recognized for his groundbreaking work in epidemiology, transmission, and prevention of diseases like malaria, dengue, and Zika. His research focuses on innovative methods for disease control and the development of strategies to mitigate the impact of vector-borne illnesses on global health. Dr. Jin has received the Best Researcher Award for his significant contributions to public health and vector control science, influencing policy and practical approaches to combatting infectious diseases worldwide.

Professional Profiles

Scopus Profile

Orcid Profile

📚Education

Prof. Huaibing Jin obtained his PhD in Genetics from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences in 2019. Following his PhD, he pursued post-doctoral research at the same institution. In 2022, he joined the Institute of Plant Protection, Chinese Academy of Agricultural Sciences, where he was selected as a “young talent”. His academic background is focused on genetics, plant virology, and insect-vector interactions.

💼Experience

Prof. Huaibing Jin worked as a post-doctoral researcher at the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences following his PhD. In 2022, he became a faculty member at the Institute of Plant Protection, Chinese Academy of Agricultural Sciences. There, he was recognized as a “young talent”. His professional experience focuses on crop viruses, viral transmission mechanisms, and vector-borne diseases. He has contributed significantly to research in plant virology and genetic interactions.

🔬Research Interest

Prof. Huaibing Jin’s research interests focus on two main areas: the interactions between crop viruses and their hosts, and the mechanisms of viral transmission by insect vectors. He studies how viruses like the barley yellow dwarf virus and rice stripe virus interact with plants at the genetic and molecular levels. Prof. Jin is particularly interested in understanding the complex processes that allow insect vectors to transmit these viruses, aiming to uncover new strategies for controlling the spread of vector-borne plant diseases. His work plays a critical role in advancing agricultural disease management.

👩‍🏫Technical Skills

Prof. Huaibing Jin has expertise in virus-host interactions, focusing on the mechanisms through which crop viruses affect their plant hosts. He is skilled in viral transmission mechanisms, particularly those involving insect vectors. His technical skills also include genetic analysis to investigate viral pathogenesis and transmission pathways. Additionally, he is proficient in studying insect-vector biology and its role in the spread of plant viruses. These skills are central to his research on vector-borne diseases and crop protection.

🎤Academic Citations

Prof. Huaibing Jin has made significant contributions to the field of plant virology, with his research being published in several prestigious journals. His work has appeared in top-tier scientific publications such as Nature Genetics, Science Advances, EMBO Journal, PNAS, and Cell Reports. These citations reflect his influential research on virus-host interactions, viral transmission mechanisms, and insect vector studies. Prof. Jin’s publications are widely recognized for advancing the understanding of crop viruses and their impact on agricultural systems.

📑Top Note Publications

Title: N6-methyladenosine modification of the mRNA for a key gene in purine nucleotide metabolism regulates virus proliferation in an insect vector.

Authors: Mengjie Zhu, Nan Wu, Jiayi Zhong, Chen Chen, Wenwen Liu, Yingdang Ren, Xifeng Wang, Huaibing Jin.
Publication Year: 2024
Citations: 3

Title: A novel module regulating ROS in NLR-mediated immunity.

Authors: Huaibing Jin, Daowen Wang, Xifeng Wang.
Publication Year: 2023
Citations: 8

Title: Barley GRIK1-SnRK1 kinases subvert a viral virulence protein to upregulate antiviral RNAi and inhibit infection.

Authors: Huaibing Jin, Xinyun Han, Zhaohui Wang, Yilin Xie, Kunpu Zhang, Xiaoge Zhao, Lina Wang, Jin Yang, Huiyun Liu, Xiang Ji, Lingli Dong, Hongyuan Zheng, Weijuan Hu, Yan Liu, Xifeng Wang, Xueping Zhou, Yijing Zhang, Weiqiang Qian, Wenming Zheng, Qianhua Shen, Mingyue Gou, Daowen Wang.
Publication Year: 2022
Citations: 11

Title: Wheat heat tolerance is impaired by heightened deletions in the distal end of 4AL chromosomal arm.

Authors: H. Zhai, C. Jiang, Y. Zhao, G. Li, D. Wang.
Publication Year: 2021
Citations: 16

Title: Efficient expression and function of a receptor-like kinase in wheat powdery mildew defence require an intron-located MYB binding site.

Authors: T. Xia, Y. Yang, H. Zheng, D. Wang, K. Zhang.
Publication Year: 2021
Citations: 15

Title: A high-quality genome assembly highlights rye genomic characteristics and agronomically important genes.

Authors: G. Li, L. Wang, J. Yang, K. Zhang, D. Wang.
Publication Year: 2021
Citations: 18